Cardinal Health (CAH) Q1 2026 Earnings
Cardinal Health reported Q1 2026 revenue of $60.9B (+11.0% YoY), missed analyst consensus of $62.1B by $1.2B. Diluted EPS came in at $3.17 (+34.9% YoY), beat the $2.79 consensus by $0.38. Cardinal Health reports across 4 business segments, led by Pharmaceutical and Specialty Solutions, Global Medical Products and Distribution (GMPD), and Nuclear and Precision Health Solutions.
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Cardinal Health's Q1 2026 earnings report.
Cardinal Health (CAH) reported Q1 2026 earnings on April 30, 2026 before market open.
Cardinal Health reported revenue of $60.9B and diluted EPS of $3.17 for Q1 2026.
Revenue missed the consensus estimate of $62.1B by $1.2B. EPS beat the consensus estimate of $2.79 by $0.38.
Compared to the same quarter a year prior, revenue grew 11.0% from $54.9B a year earlier and diluted EPS grew 34.9% from $2.35.
You can read the 8-K earnings release (0000721371-26-000017) and the 10-Q periodic report (0000721371-26-000018) directly on SEC EDGAR. The filing index links above go to sec.gov.